{{Rsnum
|rsid=743409
|Gene=MAPK1
|Chromosome=22
|position=21774926
|Orientation=minus
|GMAF=0.4449
|Gene_s=MAPK1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 42.5 | 26.5
| HCB | 21.2 | 54.0 | 24.8
| JPT | 16.2 | 49.5 | 34.2
| YRI | 46.9 | 44.9 | 8.2
| ASW | 37.5 | 44.6 | 17.9
| CHB | 21.2 | 54.0 | 24.8
| CHD | 22.9 | 58.7 | 18.3
| GIH | 34.3 | 41.4 | 24.2
| LWK | 41.8 | 50.0 | 8.2
| MEX | 40.4 | 38.6 | 21.1
| MKK | 45.5 | 39.7 | 14.7
| TSI | 31.4 | 52.0 | 16.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=22517515
|Title=MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk
}}

{{PMID|18466469|OA=1
}} Genome-wide analysis of single-locus and epistasis single-nucleotide polymorphism effects on anti-cyclic citrullinated peptide as a measure of rheumatoid arthritis.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}